Savara, Inc.

Historical 13F Holders

Symbol
SVRA
CUSIP
805111101
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 805111101 since 12/18/2024, largest first.

Filer % of Class Filed
Growth Equity Opportunities 17, LLC 13D/A
12.0% 11/14/2025
Event 11/12/2025
Bain Capital Life Sciences Fund II, L.P. 13D/A
10.0% 3/27/2025
Event 3/25/2025
Venrock Healthcare Capital Partners III, L.P. 13G/A
9.9% 2/17/2026
Event 12/31/2025
Farallon Capital Partners, L.P. 13G/A
6.9% 2/5/2026
Event 12/31/2025
Farallon Capital Management, L.L.C. 13G/A
6.8% 8/14/2026
Event 6/30/2026
James E. Flynn 13G
6.7% 11/5/2025
Event 10/30/2025
TCG Crossover GP I, LLC 13G/A
6.1% 2/17/2026
Event 12/31/2025
Polar Capital Holdings Plc 13G
5.6% 11/16/2026
Event 9/30/2026
BlackRock, Inc. 13G 5.4% 1/21/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Frazier Life Sciences Public Fund, L.P. 13G/A
4.1% 2/13/2026
Event 12/31/2025
Nantahala Capital Management, LLC 13G/A
3.6% 2/13/2026
Event 12/31/2025
Wellington Management Group LLP 13G/A
3.2% 2/10/2025
Event 12/31/2024
Vestal Point Capital, LP 13G/A
2.3% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 185 224 M $1.16B
2026 Q2 183 217 M $1.34B
2026 Q1 188 212 M $1.16B
2025 Q4 149 201 M $1.21B
2025 Q3 127 163 M $582M
2025 Q2 126 168 M $382M
2025 Q1 138 165 M $457M
2024 Q4 137 163 M $500M
2024 Q3 127 160 M $680M
2024 Q2 135 148 M $597M
2024 Q1 122 121 M $603M
2023 Q4 99 119 M $559M
2023 Q3 86 117 M $441M
2023 Q2 78 89.1 M $285M
2023 Q1 70 83.5 M $163M
2022 Q4 57 80.5 M $125M
2022 Q3 58 79.9 M $124M
2022 Q2 56 77.2 M $117M
2022 Q1 55 75.9 M $99.4M
2021 Q4 57 74.7 M $92.6M
2021 Q3 60 75.0 M $104M
2021 Q2 78 76.2 M $130M
2021 Q1 86 75.4 M $158M
2020 Q4 68 21.7 M $24.9M
2020 Q3 73 22.2 M $41.6M
2020 Q2 75 24.7 M $71.7M
2020 Q1 75 24.0 M $62.8M
2019 Q4 80 20.8 M $92.7M
2019 Q3 76 15.2 M $40.2M
2019 Q2 84 17.1 M $40.6M
2019 Q1 83 16.4 M $121M
2018 Q4 80 17.1 M $129M
2018 Q3 85 18.0 M $201M
2018 Q2 77 14.8 M $167M
2018 Q1 61 13.0 M $119M
2017 Q4 49 11.7 M $173M
2017 Q3 20 4.42 M $41.5M
2017 Q2 21 3.98 M $23.4M
2016 Q1 1 142 $1.00k